nodes	percent_of_prediction	percent_of_DWPC	metapath
Oseltamivir—CES1—Capecitabine—prostate cancer	0.272	0.512	CbGbCtD
Oseltamivir—ABCC4—Conjugated Estrogens—prostate cancer	0.119	0.224	CbGbCtD
Oseltamivir—SLC22A8—Conjugated Estrogens—prostate cancer	0.0745	0.14	CbGbCtD
Oseltamivir—SLC22A8—Estradiol—prostate cancer	0.0654	0.123	CbGbCtD
Oseltamivir—NEU1—prostate gland—prostate cancer	0.00916	0.142	CbGeAlD
Oseltamivir—NEU1—seminal vesicle—prostate cancer	0.00774	0.12	CbGeAlD
Oseltamivir—SLC22A8—urine—prostate cancer	0.00685	0.106	CbGeAlD
Oseltamivir—NEU1—urethra—prostate cancer	0.00613	0.0953	CbGeAlD
Oseltamivir—NEU1—bone marrow—prostate cancer	0.00472	0.0733	CbGeAlD
Oseltamivir—NEU1—testis—prostate cancer	0.00403	0.0627	CbGeAlD
Oseltamivir—CES1—prostate gland—prostate cancer	0.00368	0.0572	CbGeAlD
Oseltamivir—NEU1—lymph node—prostate cancer	0.00292	0.0454	CbGeAlD
Oseltamivir—SLC15A1—epithelium—prostate cancer	0.00251	0.039	CbGeAlD
Oseltamivir—ABCC4—prostate gland—prostate cancer	0.00248	0.0385	CbGeAlD
Oseltamivir—SLC22A8—prostate gland—prostate cancer	0.00246	0.0382	CbGeAlD
Oseltamivir—SLC15A1—renal system—prostate cancer	0.00233	0.0362	CbGeAlD
Oseltamivir—ABCC4—renal system—prostate cancer	0.00169	0.0262	CbGeAlD
Oseltamivir—SLC22A8—renal system—prostate cancer	0.00168	0.026	CbGeAlD
Oseltamivir—CES1—testis—prostate cancer	0.00162	0.0252	CbGeAlD
Oseltamivir—ABCC4—bone marrow—prostate cancer	0.00128	0.0198	CbGeAlD
Oseltamivir—CES1—lymph node—prostate cancer	0.00118	0.0183	CbGeAlD
Oseltamivir—ABCC4—testis—prostate cancer	0.00109	0.017	CbGeAlD
Oseltamivir—ABCC4—lymph node—prostate cancer	0.000791	0.0123	CbGeAlD
Oseltamivir—Body temperature increased—Mitoxantrone—prostate cancer	0.000123	0.000506	CcSEcCtD
Oseltamivir—Abdominal pain—Mitoxantrone—prostate cancer	0.000123	0.000506	CcSEcCtD
Oseltamivir—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	0.000123	0.000506	CcSEcCtD
Oseltamivir—Bronchitis—Epirubicin—prostate cancer	0.000123	0.000504	CcSEcCtD
Oseltamivir—Nasopharyngitis—Doxorubicin—prostate cancer	0.000123	0.000502	CcSEcCtD
Oseltamivir—Eye disorder—Prednisone—prostate cancer	0.000122	0.000502	CcSEcCtD
Oseltamivir—Anaemia—Docetaxel—prostate cancer	0.000122	0.000501	CcSEcCtD
Oseltamivir—Asthenia—Estradiol—prostate cancer	0.00012	0.000493	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000119	0.000487	CcSEcCtD
Oseltamivir—Asthma—Doxorubicin—prostate cancer	0.000118	0.000485	CcSEcCtD
Oseltamivir—Influenza—Doxorubicin—prostate cancer	0.000118	0.000485	CcSEcCtD
Oseltamivir—Anaemia—Capecitabine—prostate cancer	0.000118	0.000485	CcSEcCtD
Oseltamivir—Immune system disorder—Prednisone—prostate cancer	0.000118	0.000485	CcSEcCtD
Oseltamivir—Arrhythmia—Prednisone—prostate cancer	0.000117	0.000479	CcSEcCtD
Oseltamivir—Cough—Docetaxel—prostate cancer	0.000115	0.000473	CcSEcCtD
Oseltamivir—Angina pectoris—Doxorubicin—prostate cancer	0.000115	0.000473	CcSEcCtD
Oseltamivir—Vertigo—Capecitabine—prostate cancer	0.000115	0.000471	CcSEcCtD
Oseltamivir—Hypersensitivity—Mitoxantrone—prostate cancer	0.000115	0.000471	CcSEcCtD
Oseltamivir—Pneumonia—Epirubicin—prostate cancer	0.000115	0.00047	CcSEcCtD
Oseltamivir—Mental disorder—Prednisone—prostate cancer	0.000115	0.00047	CcSEcCtD
Oseltamivir—Diarrhoea—Estradiol—prostate cancer	0.000115	0.00047	CcSEcCtD
Oseltamivir—Convulsion—Docetaxel—prostate cancer	0.000115	0.000469	CcSEcCtD
Oseltamivir—Infestation NOS—Epirubicin—prostate cancer	0.000114	0.000468	CcSEcCtD
Oseltamivir—Infestation—Epirubicin—prostate cancer	0.000114	0.000468	CcSEcCtD
Oseltamivir—Bronchitis—Doxorubicin—prostate cancer	0.000114	0.000467	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000113	0.000464	CcSEcCtD
Oseltamivir—Arthralgia—Docetaxel—prostate cancer	0.000113	0.000461	CcSEcCtD
Oseltamivir—Myalgia—Docetaxel—prostate cancer	0.000113	0.000461	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Etoposide—prostate cancer	0.000112	0.000459	CcSEcCtD
Oseltamivir—Asthenia—Mitoxantrone—prostate cancer	0.000112	0.000459	CcSEcCtD
Oseltamivir—Fatigue—Etoposide—prostate cancer	0.000112	0.000459	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000112	0.000458	CcSEcCtD
Oseltamivir—Cough—Capecitabine—prostate cancer	0.000112	0.000458	CcSEcCtD
Oseltamivir—Jaundice—Epirubicin—prostate cancer	0.000111	0.000456	CcSEcCtD
Oseltamivir—Pain—Etoposide—prostate cancer	0.000111	0.000455	CcSEcCtD
Oseltamivir—Conjunctivitis—Epirubicin—prostate cancer	0.000111	0.000455	CcSEcCtD
Oseltamivir—Dizziness—Estradiol—prostate cancer	0.000111	0.000454	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Doxorubicin—prostate cancer	0.00011	0.000451	CcSEcCtD
Oseltamivir—Myalgia—Capecitabine—prostate cancer	0.000109	0.000447	CcSEcCtD
Oseltamivir—Arthralgia—Capecitabine—prostate cancer	0.000109	0.000447	CcSEcCtD
Oseltamivir—Confusional state—Docetaxel—prostate cancer	0.000109	0.000446	CcSEcCtD
Oseltamivir—Anxiety—Capecitabine—prostate cancer	0.000109	0.000445	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000108	0.000443	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Epirubicin—prostate cancer	0.000108	0.000442	CcSEcCtD
Oseltamivir—Anaphylactic shock—Docetaxel—prostate cancer	0.000108	0.000442	CcSEcCtD
Oseltamivir—Epistaxis—Epirubicin—prostate cancer	0.000108	0.000441	CcSEcCtD
Oseltamivir—Infection—Docetaxel—prostate cancer	0.000107	0.000439	CcSEcCtD
Oseltamivir—Sinusitis—Epirubicin—prostate cancer	0.000107	0.000439	CcSEcCtD
Oseltamivir—Feeling abnormal—Etoposide—prostate cancer	0.000107	0.000438	CcSEcCtD
Oseltamivir—Diarrhoea—Mitoxantrone—prostate cancer	0.000107	0.000438	CcSEcCtD
Oseltamivir—Vomiting—Estradiol—prostate cancer	0.000107	0.000436	CcSEcCtD
Oseltamivir—Pneumonia—Doxorubicin—prostate cancer	0.000106	0.000435	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Etoposide—prostate cancer	0.000106	0.000435	CcSEcCtD
Oseltamivir—Nervous system disorder—Docetaxel—prostate cancer	0.000106	0.000434	CcSEcCtD
Oseltamivir—Thrombocytopenia—Docetaxel—prostate cancer	0.000106	0.000433	CcSEcCtD
Oseltamivir—Rash—Estradiol—prostate cancer	0.000106	0.000433	CcSEcCtD
Oseltamivir—Infestation NOS—Doxorubicin—prostate cancer	0.000106	0.000433	CcSEcCtD
Oseltamivir—Infestation—Doxorubicin—prostate cancer	0.000106	0.000433	CcSEcCtD
Oseltamivir—Dermatitis—Estradiol—prostate cancer	0.000106	0.000432	CcSEcCtD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—TP53—prostate cancer	0.000106	0.000658	CbGpPWpGaD
Oseltamivir—Anaemia—Prednisone—prostate cancer	0.000105	0.000432	CcSEcCtD
Oseltamivir—Confusional state—Capecitabine—prostate cancer	0.000105	0.000432	CcSEcCtD
Oseltamivir—ABCC4—Platelet degranulation—IGF1—prostate cancer	0.000105	0.000656	CbGpPWpGaD
Oseltamivir—Headache—Estradiol—prostate cancer	0.000105	0.00043	CcSEcCtD
Oseltamivir—Skin disorder—Docetaxel—prostate cancer	0.000105	0.000429	CcSEcCtD
Oseltamivir—Agitation—Prednisone—prostate cancer	0.000105	0.000429	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GNG5—prostate cancer	0.000105	0.000654	CbGpPWpGaD
Oseltamivir—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000105	0.000429	CcSEcCtD
Oseltamivir—Angioedema—Prednisone—prostate cancer	0.000104	0.000427	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—TGFBR2—prostate cancer	0.000104	0.000649	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—GSTP1—prostate cancer	0.000104	0.000649	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—PLAUR—prostate cancer	0.000104	0.000649	CbGpPWpGaD
Oseltamivir—Infection—Capecitabine—prostate cancer	0.000104	0.000425	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000103	0.000644	CbGpPWpGaD
Oseltamivir—Urticaria—Etoposide—prostate cancer	0.000103	0.000423	CcSEcCtD
Oseltamivir—Jaundice—Doxorubicin—prostate cancer	0.000103	0.000422	CcSEcCtD
Oseltamivir—Abdominal pain—Etoposide—prostate cancer	0.000103	0.000421	CcSEcCtD
Oseltamivir—Body temperature increased—Etoposide—prostate cancer	0.000103	0.000421	CcSEcCtD
Oseltamivir—Conjunctivitis—Doxorubicin—prostate cancer	0.000103	0.000421	CcSEcCtD
Oseltamivir—Nervous system disorder—Capecitabine—prostate cancer	0.000103	0.00042	CcSEcCtD
Oseltamivir—Vertigo—Prednisone—prostate cancer	0.000102	0.00042	CcSEcCtD
Oseltamivir—Hepatitis—Epirubicin—prostate cancer	0.000102	0.00042	CcSEcCtD
Oseltamivir—NEU2—Metabolism—HSD3B1—prostate cancer	0.000102	0.000639	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—SLC22A3—prostate cancer	0.000102	0.000639	CbGpPWpGaD
Oseltamivir—Thrombocytopenia—Capecitabine—prostate cancer	0.000102	0.000419	CcSEcCtD
Oseltamivir—Skin disorder—Capecitabine—prostate cancer	0.000102	0.000416	CcSEcCtD
Oseltamivir—NEU1—Metabolism—NCOA3—prostate cancer	0.000101	0.00063	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000101	0.000628	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000101	0.000628	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—THBS1—prostate cancer	0.000101	0.000627	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—prostate cancer	0.0001	0.000625	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—SERPINE1—prostate cancer	0.0001	0.000623	CbGpPWpGaD
Oseltamivir—Hepatobiliary disease—Doxorubicin—prostate cancer	9.99e-05	0.000409	CcSEcCtD
Oseltamivir—Epistaxis—Doxorubicin—prostate cancer	9.96e-05	0.000408	CcSEcCtD
Oseltamivir—Nausea—Estradiol—prostate cancer	9.96e-05	0.000408	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	9.94e-05	0.00062	CbGpPWpGaD
Oseltamivir—Vomiting—Mitoxantrone—prostate cancer	9.93e-05	0.000407	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	9.92e-05	0.000619	CbGpPWpGaD
Oseltamivir—Sinusitis—Doxorubicin—prostate cancer	9.91e-05	0.000406	CcSEcCtD
Oseltamivir—Convulsion—Prednisone—prostate cancer	9.88e-05	0.000405	CcSEcCtD
Oseltamivir—Visual impairment—Epirubicin—prostate cancer	9.88e-05	0.000405	CcSEcCtD
Oseltamivir—Rash—Mitoxantrone—prostate cancer	9.85e-05	0.000403	CcSEcCtD
Oseltamivir—Dermatitis—Mitoxantrone—prostate cancer	9.84e-05	0.000403	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Docetaxel—prostate cancer	9.84e-05	0.000403	CcSEcCtD
Oseltamivir—NEU2—Metabolism—TBXAS1—prostate cancer	9.82e-05	0.000613	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTA4—prostate cancer	9.82e-05	0.000613	CbGpPWpGaD
Oseltamivir—Headache—Mitoxantrone—prostate cancer	9.78e-05	0.000401	CcSEcCtD
Oseltamivir—Insomnia—Docetaxel—prostate cancer	9.76e-05	0.0004	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PRKCZ—prostate cancer	9.73e-05	0.000606	CbGpPWpGaD
Oseltamivir—Myalgia—Prednisone—prostate cancer	9.71e-05	0.000398	CcSEcCtD
Oseltamivir—Arthralgia—Prednisone—prostate cancer	9.71e-05	0.000398	CcSEcCtD
Oseltamivir—Erythema multiforme—Epirubicin—prostate cancer	9.69e-05	0.000397	CcSEcCtD
Oseltamivir—Anxiety—Prednisone—prostate cancer	9.68e-05	0.000396	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	9.65e-05	0.000395	CcSEcCtD
Oseltamivir—NEU1—Metabolism—HPGDS—prostate cancer	9.63e-05	0.000601	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	9.6e-05	0.000599	CbGpPWpGaD
Oseltamivir—Eye disorder—Epirubicin—prostate cancer	9.58e-05	0.000392	CcSEcCtD
Oseltamivir—NEU2—Metabolism—GSTA2—prostate cancer	9.57e-05	0.000597	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP2C19—prostate cancer	9.57e-05	0.000597	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Etoposide—prostate cancer	9.57e-05	0.000392	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—GSTM1—prostate cancer	9.57e-05	0.000597	CbGpPWpGaD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	9.56e-05	0.000596	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—prostate cancer	9.52e-05	0.000594	CbGpPWpGaD
Oseltamivir—Musculoskeletal discomfort—Capecitabine—prostate cancer	9.52e-05	0.00039	CcSEcCtD
Oseltamivir—Cardiac disorder—Epirubicin—prostate cancer	9.51e-05	0.00039	CcSEcCtD
Oseltamivir—Dyspepsia—Docetaxel—prostate cancer	9.5e-05	0.000389	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—LEP—prostate cancer	9.5e-05	0.000592	CbGpPWpGaD
Oseltamivir—Hepatitis—Doxorubicin—prostate cancer	9.48e-05	0.000388	CcSEcCtD
Oseltamivir—NEU2—Metabolism—ABCG5—prostate cancer	9.46e-05	0.00059	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—SULT1A1—prostate cancer	9.46e-05	0.00059	CbGpPWpGaD
Oseltamivir—Insomnia—Capecitabine—prostate cancer	9.45e-05	0.000387	CcSEcCtD
Oseltamivir—NEU1—Metabolism—ACHE—prostate cancer	9.34e-05	0.000583	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTT1—prostate cancer	9.34e-05	0.000583	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Docetaxel—prostate cancer	9.32e-05	0.000382	CcSEcCtD
Oseltamivir—Asthenia—Etoposide—prostate cancer	9.32e-05	0.000382	CcSEcCtD
Oseltamivir—Anaphylactic shock—Prednisone—prostate cancer	9.31e-05	0.000381	CcSEcCtD
Oseltamivir—Fatigue—Docetaxel—prostate cancer	9.31e-05	0.000381	CcSEcCtD
Oseltamivir—Nausea—Mitoxantrone—prostate cancer	9.28e-05	0.00038	CcSEcCtD
Oseltamivir—Immune system disorder—Epirubicin—prostate cancer	9.26e-05	0.000379	CcSEcCtD
Oseltamivir—Infection—Prednisone—prostate cancer	9.25e-05	0.000379	CcSEcCtD
Oseltamivir—Mediastinal disorder—Epirubicin—prostate cancer	9.24e-05	0.000378	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CYP2A6—prostate cancer	9.24e-05	0.000576	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTA1—prostate cancer	9.24e-05	0.000576	CbGpPWpGaD
Oseltamivir—Pain—Docetaxel—prostate cancer	9.23e-05	0.000378	CcSEcCtD
Oseltamivir—Dyspepsia—Capecitabine—prostate cancer	9.2e-05	0.000377	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	9.2e-05	0.000574	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—FGFR2—prostate cancer	9.19e-05	0.000573	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—CYP7B1—prostate cancer	9.19e-05	0.000573	CbGpPWpGaD
Oseltamivir—Arrhythmia—Epirubicin—prostate cancer	9.16e-05	0.000375	CcSEcCtD
Oseltamivir—Visual impairment—Doxorubicin—prostate cancer	9.14e-05	0.000374	CcSEcCtD
Oseltamivir—NEU2—Metabolism—NAT2—prostate cancer	9.13e-05	0.000569	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTO1—prostate cancer	9.13e-05	0.000569	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—HSD3B2—prostate cancer	9.13e-05	0.000569	CbGpPWpGaD
Oseltamivir—Nervous system disorder—Prednisone—prostate cancer	9.13e-05	0.000374	CcSEcCtD
Oseltamivir—Skin disorder—Prednisone—prostate cancer	9.04e-05	0.00037	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Capecitabine—prostate cancer	9.02e-05	0.00037	CcSEcCtD
Oseltamivir—Fatigue—Capecitabine—prostate cancer	9.01e-05	0.000369	CcSEcCtD
Oseltamivir—NEU1—Metabolism—AKR1C3—prostate cancer	8.98e-05	0.00056	CbGpPWpGaD
Oseltamivir—Mental disorder—Epirubicin—prostate cancer	8.98e-05	0.000368	CcSEcCtD
Oseltamivir—Erythema multiforme—Doxorubicin—prostate cancer	8.97e-05	0.000367	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC12A2—prostate cancer	8.95e-05	0.000558	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC26A4—prostate cancer	8.95e-05	0.000558	CbGpPWpGaD
Oseltamivir—Pain—Capecitabine—prostate cancer	8.94e-05	0.000366	CcSEcCtD
Oseltamivir—NEU1—Metabolism—PRKACB—prostate cancer	8.94e-05	0.000557	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Docetaxel—prostate cancer	8.9e-05	0.000364	CcSEcCtD
Oseltamivir—Diarrhoea—Etoposide—prostate cancer	8.89e-05	0.000364	CcSEcCtD
Oseltamivir—Eye disorder—Doxorubicin—prostate cancer	8.86e-05	0.000363	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CYP17A1—prostate cancer	8.85e-05	0.000551	CbGpPWpGaD
Oseltamivir—Gastrointestinal pain—Docetaxel—prostate cancer	8.83e-05	0.000362	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—CYP7B1—prostate cancer	8.81e-05	0.000549	CbGpPWpGaD
Oseltamivir—Cardiac disorder—Doxorubicin—prostate cancer	8.8e-05	0.00036	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	8.78e-05	0.000548	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP2C18—prostate cancer	8.76e-05	0.000546	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—LRP2—prostate cancer	8.76e-05	0.000546	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PLCB2—prostate cancer	8.76e-05	0.000546	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	8.72e-05	0.000544	CbGpPWpGaD
Oseltamivir—Back pain—Epirubicin—prostate cancer	8.63e-05	0.000353	CcSEcCtD
Oseltamivir—Feeling abnormal—Capecitabine—prostate cancer	8.61e-05	0.000353	CcSEcCtD
Oseltamivir—Dizziness—Etoposide—prostate cancer	8.59e-05	0.000352	CcSEcCtD
Oseltamivir—NEU2—Metabolism—P4HB—prostate cancer	8.59e-05	0.000535	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC26A4—prostate cancer	8.58e-05	0.000535	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC12A2—prostate cancer	8.58e-05	0.000535	CbGpPWpGaD
Oseltamivir—Immune system disorder—Doxorubicin—prostate cancer	8.57e-05	0.000351	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Capecitabine—prostate cancer	8.55e-05	0.00035	CcSEcCtD
Oseltamivir—Mediastinal disorder—Doxorubicin—prostate cancer	8.55e-05	0.00035	CcSEcCtD
Oseltamivir—Abdominal pain—Docetaxel—prostate cancer	8.53e-05	0.00035	CcSEcCtD
Oseltamivir—Body temperature increased—Docetaxel—prostate cancer	8.53e-05	0.00035	CcSEcCtD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	8.5e-05	0.00053	CbGpPWpGaD
Oseltamivir—Musculoskeletal discomfort—Prednisone—prostate cancer	8.48e-05	0.000347	CcSEcCtD
Oseltamivir—Arrhythmia—Doxorubicin—prostate cancer	8.47e-05	0.000347	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—ITGA6—prostate cancer	8.43e-05	0.000526	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—NCOA2—prostate cancer	8.43e-05	0.000526	CbGpPWpGaD
Oseltamivir—Insomnia—Prednisone—prostate cancer	8.42e-05	0.000345	CcSEcCtD
Oseltamivir—NEU2—Metabolism—SLC22A1—prostate cancer	8.35e-05	0.000521	CbGpPWpGaD
Oseltamivir—Mental disorder—Doxorubicin—prostate cancer	8.31e-05	0.00034	CcSEcCtD
Oseltamivir—Urticaria—Capecitabine—prostate cancer	8.3e-05	0.00034	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PRKCQ—prostate cancer	8.27e-05	0.000516	CbGpPWpGaD
Oseltamivir—Body temperature increased—Capecitabine—prostate cancer	8.26e-05	0.000338	CcSEcCtD
Oseltamivir—Abdominal pain—Capecitabine—prostate cancer	8.26e-05	0.000338	CcSEcCtD
Oseltamivir—Vomiting—Etoposide—prostate cancer	8.26e-05	0.000338	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	8.26e-05	0.000515	CbGpPWpGaD
Oseltamivir—Anaemia—Epirubicin—prostate cancer	8.25e-05	0.000338	CcSEcCtD
Oseltamivir—Agitation—Epirubicin—prostate cancer	8.2e-05	0.000336	CcSEcCtD
Oseltamivir—Dyspepsia—Prednisone—prostate cancer	8.2e-05	0.000336	CcSEcCtD
Oseltamivir—Rash—Etoposide—prostate cancer	8.19e-05	0.000335	CcSEcCtD
Oseltamivir—Dermatitis—Etoposide—prostate cancer	8.18e-05	0.000335	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	8.17e-05	0.000509	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—SULT2A1—prostate cancer	8.14e-05	0.000508	CbGpPWpGaD
Oseltamivir—Headache—Etoposide—prostate cancer	8.14e-05	0.000333	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—INS—prostate cancer	8.12e-05	0.000506	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—SLC5A5—prostate cancer	8.04e-05	0.000501	CbGpPWpGaD
Oseltamivir—Fatigue—Prednisone—prostate cancer	8.03e-05	0.000329	CcSEcCtD
Oseltamivir—Vertigo—Epirubicin—prostate cancer	8.02e-05	0.000328	CcSEcCtD
Oseltamivir—NEU2—Metabolism—MED12—prostate cancer	8.01e-05	0.000499	CbGpPWpGaD
Oseltamivir—Back pain—Doxorubicin—prostate cancer	7.99e-05	0.000327	CcSEcCtD
Oseltamivir—Hypersensitivity—Docetaxel—prostate cancer	7.95e-05	0.000326	CcSEcCtD
Oseltamivir—NEU2—Metabolism—GNG5—prostate cancer	7.95e-05	0.000495	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CD9—prostate cancer	7.93e-05	0.000494	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP2E1—prostate cancer	7.85e-05	0.00049	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—IGF1—prostate cancer	7.85e-05	0.00049	CbGpPWpGaD
Oseltamivir—Cough—Epirubicin—prostate cancer	7.79e-05	0.000319	CcSEcCtD
Oseltamivir—NEU1—Metabolism—NQO1—prostate cancer	7.77e-05	0.000484	CbGpPWpGaD
Oseltamivir—Asthenia—Docetaxel—prostate cancer	7.75e-05	0.000317	CcSEcCtD
Oseltamivir—Convulsion—Epirubicin—prostate cancer	7.73e-05	0.000317	CcSEcCtD
Oseltamivir—Nausea—Etoposide—prostate cancer	7.72e-05	0.000316	CcSEcCtD
Oseltamivir—Hypersensitivity—Capecitabine—prostate cancer	7.7e-05	0.000315	CcSEcCtD
Oseltamivir—Feeling abnormal—Prednisone—prostate cancer	7.67e-05	0.000314	CcSEcCtD
Oseltamivir—NEU1—Metabolism—TH—prostate cancer	7.65e-05	0.000477	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NCOA3—prostate cancer	7.65e-05	0.000477	CbGpPWpGaD
Oseltamivir—Anaemia—Doxorubicin—prostate cancer	7.63e-05	0.000313	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Prednisone—prostate cancer	7.61e-05	0.000312	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	7.6e-05	0.000474	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—MMP2—prostate cancer	7.6e-05	0.000474	CbGpPWpGaD
Oseltamivir—Arthralgia—Epirubicin—prostate cancer	7.6e-05	0.000311	CcSEcCtD
Oseltamivir—Myalgia—Epirubicin—prostate cancer	7.6e-05	0.000311	CcSEcCtD
Oseltamivir—Agitation—Doxorubicin—prostate cancer	7.59e-05	0.000311	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—VAV3—prostate cancer	7.58e-05	0.000473	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP3A4—prostate cancer	7.57e-05	0.000472	CbGpPWpGaD
Oseltamivir—Anxiety—Epirubicin—prostate cancer	7.57e-05	0.00031	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	7.54e-05	0.000309	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ABCG5—prostate cancer	7.54e-05	0.00047	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	7.53e-05	0.00047	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	7.52e-05	0.000469	CbGpPWpGaD
Oseltamivir—Asthenia—Capecitabine—prostate cancer	7.5e-05	0.000307	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CYP1B1—prostate cancer	7.44e-05	0.000464	CbGpPWpGaD
Oseltamivir—Vertigo—Doxorubicin—prostate cancer	7.42e-05	0.000304	CcSEcCtD
Oseltamivir—Urticaria—Prednisone—prostate cancer	7.4e-05	0.000303	CcSEcCtD
Oseltamivir—Diarrhoea—Docetaxel—prostate cancer	7.39e-05	0.000303	CcSEcCtD
Oseltamivir—Body temperature increased—Prednisone—prostate cancer	7.36e-05	0.000301	CcSEcCtD
Oseltamivir—Abdominal pain—Prednisone—prostate cancer	7.36e-05	0.000301	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—ITPR1—prostate cancer	7.36e-05	0.000459	CbGpPWpGaD
Oseltamivir—Confusional state—Epirubicin—prostate cancer	7.34e-05	0.000301	CcSEcCtD
Oseltamivir—NEU2—Metabolism—HPGDS—prostate cancer	7.3e-05	0.000455	CbGpPWpGaD
Oseltamivir—Anaphylactic shock—Epirubicin—prostate cancer	7.28e-05	0.000298	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC22A3—prostate cancer	7.26e-05	0.000453	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP2C19—prostate cancer	7.26e-05	0.000452	CbGpPWpGaD
Oseltamivir—Infection—Epirubicin—prostate cancer	7.23e-05	0.000296	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—TGFB1—prostate cancer	7.22e-05	0.00045	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GGT1—prostate cancer	7.21e-05	0.00045	CbGpPWpGaD
Oseltamivir—Cough—Doxorubicin—prostate cancer	7.2e-05	0.000295	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—LEP—prostate cancer	7.2e-05	0.000449	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CLU—prostate cancer	7.17e-05	0.000447	CbGpPWpGaD
Oseltamivir—Convulsion—Doxorubicin—prostate cancer	7.15e-05	0.000293	CcSEcCtD
Oseltamivir—Diarrhoea—Capecitabine—prostate cancer	7.15e-05	0.000293	CcSEcCtD
Oseltamivir—Nervous system disorder—Epirubicin—prostate cancer	7.14e-05	0.000292	CcSEcCtD
Oseltamivir—Dizziness—Docetaxel—prostate cancer	7.14e-05	0.000292	CcSEcCtD
Oseltamivir—Thrombocytopenia—Epirubicin—prostate cancer	7.13e-05	0.000292	CcSEcCtD
Oseltamivir—NEU1—Metabolism—NCOA1—prostate cancer	7.1e-05	0.000443	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ACHE—prostate cancer	7.08e-05	0.000442	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTT1—prostate cancer	7.08e-05	0.000442	CbGpPWpGaD
Oseltamivir—Skin disorder—Epirubicin—prostate cancer	7.07e-05	0.00029	CcSEcCtD
Oseltamivir—Myalgia—Doxorubicin—prostate cancer	7.03e-05	0.000288	CcSEcCtD
Oseltamivir—Arthralgia—Doxorubicin—prostate cancer	7.03e-05	0.000288	CcSEcCtD
Oseltamivir—Anxiety—Doxorubicin—prostate cancer	7e-05	0.000287	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CYP19A1—prostate cancer	7e-05	0.000436	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP2A6—prostate cancer	7e-05	0.000436	CbGpPWpGaD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	6.98e-05	0.000286	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.97e-05	0.000435	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC22A3—prostate cancer	6.96e-05	0.000434	CbGpPWpGaD
Oseltamivir—Dizziness—Capecitabine—prostate cancer	6.91e-05	0.000283	CcSEcCtD
Oseltamivir—ABCC4—Platelet degranulation—VEGFA—prostate cancer	6.88e-05	0.000429	CbGpPWpGaD
Oseltamivir—Vomiting—Docetaxel—prostate cancer	6.86e-05	0.000281	CcSEcCtD
Oseltamivir—Hypersensitivity—Prednisone—prostate cancer	6.86e-05	0.000281	CcSEcCtD
Oseltamivir—NEU2—Metabolism—AKR1C3—prostate cancer	6.81e-05	0.000425	CbGpPWpGaD
Oseltamivir—Rash—Docetaxel—prostate cancer	6.81e-05	0.000279	CcSEcCtD
Oseltamivir—Dermatitis—Docetaxel—prostate cancer	6.8e-05	0.000279	CcSEcCtD
Oseltamivir—Confusional state—Doxorubicin—prostate cancer	6.79e-05	0.000278	CcSEcCtD
Oseltamivir—NEU2—Metabolism—PRKACB—prostate cancer	6.77e-05	0.000422	CbGpPWpGaD
Oseltamivir—Headache—Docetaxel—prostate cancer	6.76e-05	0.000277	CcSEcCtD
Oseltamivir—NEU1—Metabolism—RXRA—prostate cancer	6.76e-05	0.000421	CbGpPWpGaD
Oseltamivir—Anaphylactic shock—Doxorubicin—prostate cancer	6.74e-05	0.000276	CcSEcCtD
Oseltamivir—NEU2—Metabolism—CYP17A1—prostate cancer	6.7e-05	0.000418	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ABCG5—prostate cancer	6.7e-05	0.000418	CbGpPWpGaD
Oseltamivir—Infection—Doxorubicin—prostate cancer	6.69e-05	0.000274	CcSEcCtD
Oseltamivir—Asthenia—Prednisone—prostate cancer	6.68e-05	0.000274	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	6.66e-05	0.000415	CbGpPWpGaD
Oseltamivir—Vomiting—Capecitabine—prostate cancer	6.65e-05	0.000272	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Epirubicin—prostate cancer	6.63e-05	0.000272	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.61e-05	0.000412	CbGpPWpGaD
Oseltamivir—Nervous system disorder—Doxorubicin—prostate cancer	6.61e-05	0.000271	CcSEcCtD
Oseltamivir—Thrombocytopenia—Doxorubicin—prostate cancer	6.6e-05	0.00027	CcSEcCtD
Oseltamivir—Rash—Capecitabine—prostate cancer	6.59e-05	0.00027	CcSEcCtD
Oseltamivir—Insomnia—Epirubicin—prostate cancer	6.59e-05	0.00027	CcSEcCtD
Oseltamivir—Dermatitis—Capecitabine—prostate cancer	6.58e-05	0.00027	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.57e-05	0.00041	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—GRB7—prostate cancer	6.56e-05	0.000409	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—prostate cancer	6.55e-05	0.000408	CbGpPWpGaD
Oseltamivir—Headache—Capecitabine—prostate cancer	6.55e-05	0.000268	CcSEcCtD
Oseltamivir—Skin disorder—Doxorubicin—prostate cancer	6.54e-05	0.000268	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—ITGB3—prostate cancer	6.51e-05	0.000406	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—COMT—prostate cancer	6.51e-05	0.000406	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTP1—prostate cancer	6.48e-05	0.000404	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ABCG5—prostate cancer	6.43e-05	0.000401	CbGpPWpGaD
Oseltamivir—Nausea—Docetaxel—prostate cancer	6.41e-05	0.000263	CcSEcCtD
Oseltamivir—Dyspepsia—Epirubicin—prostate cancer	6.41e-05	0.000263	CcSEcCtD
Oseltamivir—NEU2—Metabolism—NCOA2—prostate cancer	6.39e-05	0.000398	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ITPR1—prostate cancer	6.37e-05	0.000397	CbGpPWpGaD
Oseltamivir—Diarrhoea—Prednisone—prostate cancer	6.37e-05	0.000261	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—GNG5—prostate cancer	6.33e-05	0.000395	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—CXCL8—prostate cancer	6.31e-05	0.000394	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—TGFB1—prostate cancer	6.31e-05	0.000394	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Epirubicin—prostate cancer	6.29e-05	0.000257	CcSEcCtD
Oseltamivir—Fatigue—Epirubicin—prostate cancer	6.28e-05	0.000257	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.27e-05	0.000391	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—GNG5—prostate cancer	6.24e-05	0.000389	CbGpPWpGaD
Oseltamivir—Pain—Epirubicin—prostate cancer	6.23e-05	0.000255	CcSEcCtD
Oseltamivir—Nausea—Capecitabine—prostate cancer	6.21e-05	0.000254	CcSEcCtD
Oseltamivir—Dizziness—Prednisone—prostate cancer	6.16e-05	0.000252	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—INS—prostate cancer	6.15e-05	0.000384	CbGpPWpGaD
Oseltamivir—Musculoskeletal discomfort—Doxorubicin—prostate cancer	6.14e-05	0.000251	CcSEcCtD
Oseltamivir—Insomnia—Doxorubicin—prostate cancer	6.09e-05	0.00025	CcSEcCtD
Oseltamivir—NEU2—Metabolism—SLC5A5—prostate cancer	6.09e-05	0.00038	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—TYMS—prostate cancer	6.02e-05	0.000375	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—prostate cancer	6.01e-05	0.000375	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Epirubicin—prostate cancer	6e-05	0.000246	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Epirubicin—prostate cancer	5.95e-05	0.000244	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GSTM1—prostate cancer	5.95e-05	0.000371	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP2E1—prostate cancer	5.95e-05	0.000371	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—IGF1—prostate cancer	5.95e-05	0.000371	CbGpPWpGaD
Oseltamivir—Dyspepsia—Doxorubicin—prostate cancer	5.93e-05	0.000243	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC22A1—prostate cancer	5.92e-05	0.000369	CbGpPWpGaD
Oseltamivir—Vomiting—Prednisone—prostate cancer	5.92e-05	0.000242	CcSEcCtD
Oseltamivir—NEU2—Metabolism—NQO1—prostate cancer	5.89e-05	0.000367	CbGpPWpGaD
Oseltamivir—Rash—Prednisone—prostate cancer	5.87e-05	0.00024	CcSEcCtD
Oseltamivir—Dermatitis—Prednisone—prostate cancer	5.87e-05	0.00024	CcSEcCtD
Oseltamivir—NEU1—Metabolism—LPL—prostate cancer	5.84e-05	0.000364	CbGpPWpGaD
Oseltamivir—Headache—Prednisone—prostate cancer	5.83e-05	0.000239	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—CTNNB1—prostate cancer	5.83e-05	0.000363	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.82e-05	0.000238	CcSEcCtD
Oseltamivir—Fatigue—Doxorubicin—prostate cancer	5.81e-05	0.000238	CcSEcCtD
Oseltamivir—NEU2—Metabolism—TH—prostate cancer	5.8e-05	0.000362	CbGpPWpGaD
Oseltamivir—Urticaria—Epirubicin—prostate cancer	5.79e-05	0.000237	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.76e-05	0.000359	CbGpPWpGaD
Oseltamivir—Pain—Doxorubicin—prostate cancer	5.76e-05	0.000236	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—MMP2—prostate cancer	5.76e-05	0.000359	CbGpPWpGaD
Oseltamivir—Abdominal pain—Epirubicin—prostate cancer	5.76e-05	0.000236	CcSEcCtD
Oseltamivir—Body temperature increased—Epirubicin—prostate cancer	5.76e-05	0.000236	CcSEcCtD
Oseltamivir—NEU2—Metabolism—CYP3A4—prostate cancer	5.74e-05	0.000358	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.71e-05	0.000356	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC22A1—prostate cancer	5.68e-05	0.000354	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP1B1—prostate cancer	5.64e-05	0.000352	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP1A1—prostate cancer	5.64e-05	0.000352	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—GNG5—prostate cancer	5.63e-05	0.000351	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ERCC2—prostate cancer	5.6e-05	0.000349	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Doxorubicin—prostate cancer	5.55e-05	0.000227	CcSEcCtD
Oseltamivir—Nausea—Prednisone—prostate cancer	5.53e-05	0.000227	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Doxorubicin—prostate cancer	5.51e-05	0.000226	CcSEcCtD
Oseltamivir—NEU2—Metabolism—GGT1—prostate cancer	5.46e-05	0.000341	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—GNG5—prostate cancer	5.4e-05	0.000337	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	5.4e-05	0.000337	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NCOA1—prostate cancer	5.38e-05	0.000336	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Epirubicin—prostate cancer	5.37e-05	0.00022	CcSEcCtD
Oseltamivir—Urticaria—Doxorubicin—prostate cancer	5.35e-05	0.000219	CcSEcCtD
Oseltamivir—Body temperature increased—Doxorubicin—prostate cancer	5.33e-05	0.000218	CcSEcCtD
Oseltamivir—Abdominal pain—Doxorubicin—prostate cancer	5.33e-05	0.000218	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—PRKACB—prostate cancer	5.32e-05	0.000332	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP19A1—prostate cancer	5.3e-05	0.000331	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—MTHFR—prostate cancer	5.26e-05	0.000328	CbGpPWpGaD
Oseltamivir—Asthenia—Epirubicin—prostate cancer	5.22e-05	0.000214	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—THBS1—prostate cancer	5.18e-05	0.000323	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PPARA—prostate cancer	5.16e-05	0.000322	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—RXRA—prostate cancer	5.12e-05	0.000319	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—prostate cancer	5.1e-05	0.000318	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	5.09e-05	0.000317	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—CTNNB1—prostate cancer	5.05e-05	0.000315	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—EGF—prostate cancer	5.04e-05	0.000314	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PRKCZ—prostate cancer	5.01e-05	0.000313	CbGpPWpGaD
Oseltamivir—Diarrhoea—Epirubicin—prostate cancer	4.98e-05	0.000204	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.98e-05	0.00031	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Doxorubicin—prostate cancer	4.96e-05	0.000203	CcSEcCtD
Oseltamivir—NEU2—Metabolism—COMT—prostate cancer	4.93e-05	0.000307	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTP1—prostate cancer	4.91e-05	0.000306	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.86e-05	0.000303	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CAV1—prostate cancer	4.85e-05	0.000303	CbGpPWpGaD
Oseltamivir—Asthenia—Doxorubicin—prostate cancer	4.83e-05	0.000198	CcSEcCtD
Oseltamivir—NEU2—Metabolism—ITPR1—prostate cancer	4.83e-05	0.000301	CbGpPWpGaD
Oseltamivir—Dizziness—Epirubicin—prostate cancer	4.82e-05	0.000197	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—PRKACB—prostate cancer	4.8e-05	0.000299	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—CXCL8—prostate cancer	4.79e-05	0.000298	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.75e-05	0.000296	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—IGF1—prostate cancer	4.67e-05	0.000291	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.64e-05	0.000289	CbGpPWpGaD
Oseltamivir—Vomiting—Epirubicin—prostate cancer	4.63e-05	0.00019	CcSEcCtD
Oseltamivir—Diarrhoea—Doxorubicin—prostate cancer	4.61e-05	0.000189	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—PRKACB—prostate cancer	4.6e-05	0.000287	CbGpPWpGaD
Oseltamivir—Rash—Epirubicin—prostate cancer	4.59e-05	0.000188	CcSEcCtD
Oseltamivir—Dermatitis—Epirubicin—prostate cancer	4.59e-05	0.000188	CcSEcCtD
Oseltamivir—NEU2—Metabolism—TYMS—prostate cancer	4.56e-05	0.000285	CbGpPWpGaD
Oseltamivir—Headache—Epirubicin—prostate cancer	4.56e-05	0.000187	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.53e-05	0.000282	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTM1—prostate cancer	4.51e-05	0.000281	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—prostate cancer	4.48e-05	0.00028	CbGpPWpGaD
Oseltamivir—Dizziness—Doxorubicin—prostate cancer	4.46e-05	0.000182	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—prostate cancer	4.43e-05	0.000277	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—LPL—prostate cancer	4.43e-05	0.000276	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CG—prostate cancer	4.42e-05	0.000276	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—CTNNB1—prostate cancer	4.41e-05	0.000275	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.34e-05	0.000271	CbGpPWpGaD
Oseltamivir—Nausea—Epirubicin—prostate cancer	4.33e-05	0.000177	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.32e-05	0.000269	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.29e-05	0.000267	CbGpPWpGaD
Oseltamivir—Vomiting—Doxorubicin—prostate cancer	4.28e-05	0.000175	CcSEcCtD
Oseltamivir—NEU2—Metabolism—CYP1A1—prostate cancer	4.28e-05	0.000267	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PRKCQ—prostate cancer	4.26e-05	0.000266	CbGpPWpGaD
Oseltamivir—Rash—Doxorubicin—prostate cancer	4.25e-05	0.000174	CcSEcCtD
Oseltamivir—Dermatitis—Doxorubicin—prostate cancer	4.24e-05	0.000174	CcSEcCtD
Oseltamivir—NEU2—Metabolism—ERCC2—prostate cancer	4.24e-05	0.000264	CbGpPWpGaD
Oseltamivir—Headache—Doxorubicin—prostate cancer	4.22e-05	0.000173	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—PLAUR—prostate cancer	4.21e-05	0.000263	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—INS—prostate cancer	4.18e-05	0.000261	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.14e-05	0.000258	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—JAK2—prostate cancer	4.12e-05	0.000257	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CREBBP—prostate cancer	4.1e-05	0.000255	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—MYC—prostate cancer	4.09e-05	0.000255	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—RXRA—prostate cancer	4.08e-05	0.000254	CbGpPWpGaD
Oseltamivir—Nausea—Doxorubicin—prostate cancer	4e-05	0.000164	CcSEcCtD
Oseltamivir—NEU2—Metabolism—MTHFR—prostate cancer	3.99e-05	0.000249	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PPARA—prostate cancer	3.91e-05	0.000244	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—VAV3—prostate cancer	3.91e-05	0.000244	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—prostate cancer	3.91e-05	0.000244	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—TGFB1—prostate cancer	3.9e-05	0.000243	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CD—prostate cancer	3.89e-05	0.000242	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.81e-05	0.000238	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ITPR1—prostate cancer	3.79e-05	0.000236	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CAV1—prostate cancer	3.68e-05	0.000229	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—NOS3—prostate cancer	3.67e-05	0.000229	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.66e-05	0.000228	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—RXRA—prostate cancer	3.63e-05	0.000226	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—IL2—prostate cancer	3.59e-05	0.000224	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.51e-05	0.000219	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—RXRA—prostate cancer	3.48e-05	0.000217	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CB—prostate cancer	3.39e-05	0.000211	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ITGB3—prostate cancer	3.36e-05	0.000209	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTGS2—prostate cancer	3.36e-05	0.000209	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CG—prostate cancer	3.35e-05	0.000209	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—INS—prostate cancer	3.17e-05	0.000198	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—SRC—prostate cancer	3.13e-05	0.000195	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—PPARA—prostate cancer	3.12e-05	0.000194	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CREBBP—prostate cancer	3.11e-05	0.000194	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	3.05e-05	0.00019	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PLAU—prostate cancer	2.96e-05	0.000184	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CD—prostate cancer	2.94e-05	0.000184	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTEN—prostate cancer	2.93e-05	0.000182	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CAV1—prostate cancer	2.89e-05	0.00018	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	2.8e-05	0.000175	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—EP300—prostate cancer	2.79e-05	0.000174	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NOS3—prostate cancer	2.78e-05	0.000173	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—PPARA—prostate cancer	2.77e-05	0.000173	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—PPARA—prostate cancer	2.66e-05	0.000166	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CG—prostate cancer	2.63e-05	0.000164	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—EGF—prostate cancer	2.6e-05	0.000162	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CB—prostate cancer	2.57e-05	0.00016	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTGS2—prostate cancer	2.54e-05	0.000159	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.47e-05	0.000154	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CREBBP—prostate cancer	2.44e-05	0.000152	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IGF1—prostate cancer	2.41e-05	0.00015	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	2.38e-05	0.000149	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CD—prostate cancer	2.31e-05	0.000144	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SERPINE1—prostate cancer	2.29e-05	0.000143	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTEN—prostate cancer	2.22e-05	0.000138	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.2e-05	0.000137	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—NOS3—prostate cancer	2.18e-05	0.000136	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—JAK2—prostate cancer	2.12e-05	0.000132	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—EP300—prostate cancer	2.11e-05	0.000132	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.11e-05	0.000132	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CA—prostate cancer	2.06e-05	0.000129	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CB—prostate cancer	2.01e-05	0.000126	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—AKT1—prostate cancer	1.95e-05	0.000121	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IL2—prostate cancer	1.85e-05	0.000115	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—AKT1—prostate cancer	1.69e-05	0.000105	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—EP300—prostate cancer	1.66e-05	0.000104	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SRC—prostate cancer	1.61e-05	0.000101	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—VEGFA—prostate cancer	1.57e-05	9.8e-05	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CA—prostate cancer	1.56e-05	9.75e-05	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TGFB1—prostate cancer	1.44e-05	9e-05	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—KRAS—prostate cancer	1.34e-05	8.33e-05	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—AKT1—prostate cancer	1.28e-05	7.97e-05	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CA—prostate cancer	1.23e-05	7.66e-05	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TP53—prostate cancer	1.19e-05	7.41e-05	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—AKT1—prostate cancer	1e-05	6.26e-05	CbGpPWpGaD
